A Prospective Study of Lenalidomide Monotherapy for Relapse After Allogeneic Stem Cell Transplant fo...
A Prospective Study of Lenalidomide Monotherapy for Relapse After Allogeneic Stem Cell Transplant for Multiple Myeloma
About this item
Full title
Author / Creator
Journal title
Language
English
Formats
More information
Scope and Contents
Contents
Allogeneic stem cell transplantation (Allo-SCT) can result in long-term remissions in patients with multiple myeloma (MM), although its overall role in disease management remains controversial. We evaluated lenalidomide monotherapy response and tolerability among patients with MM who progressed (PD) or relapsed after Allo-SCT. Eighteen patients, en...
Alternative Titles
Full title
A Prospective Study of Lenalidomide Monotherapy for Relapse After Allogeneic Stem Cell Transplant for Multiple Myeloma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4028023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4028023
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/bmt.2013.219
